Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Identify a Transcriptomic Profile Indicative of Cycle AMP Pathway Activation in the Lung

NCT00331292 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00331292
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00331292 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Identify a Transcriptomic Profile Indicative of Cycle AMP Pathway Activation in the Lung
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Terminated
Start date
August 31, 2006
Completion date
Not reported
Enrollment
30
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma